HERON THERAPEUTICS, INC. /DE/: management transactions · United States · SEC (Form 4) Browse the full directors' dealings record of HERON THERAPEUTICS, INC. /DE/, a listed equity based in United States. Shares are listed on US US, under the authority of SEC (Form 4). Market capitalisation: €76.6m. The latest transaction was disclosed on 21 April 2026 (Levée d'options). Among the most active insiders: Collard Craig A. All data is free.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Last declaration on 21 April 2026
All Executives80 Thresholds0 Prospectus0 Other0
Declarations 80 total
◇ Chief Executive Officer · Executives · 19 Apr 2026
13,797 shares Common Stock SEC:0001193125-26-165365:0
◇ Chief Executive Officer · Executives · 19 Oct 2025
13,797 shares Common Stock SEC:0001193125-25-244520:0
◇ Chief Executive Officer · Executives · 19 Jul 2025
13,797 shares Common Stock SEC:0000950170-25-097488:0
◇ EVP, Chief Financial Officer · Executives · 19 Jul 2025
3,874 shares Common Stock SEC:0000950170-25-097498:0
◇ EVP, Chief Financial Officer · Executives · 30 Apr 2025
11,694 shares Common Stock SEC:0000950170-25-063063:0
◇ Chief Executive Officer · Executives · 30 Apr 2025
34,789 shares Common Stock SEC:0000950170-25-063061:0
◇ EVP, Chief Development Officer · Executives · 30 Apr 2025
11,694 shares Common Stock SEC:0000950170-25-063065:0
◇ EVP, Chief Financial Officer · Executives · 19 Apr 2025
3,875 shares Common Stock SEC:0000950170-25-056492:0
◇ EVP, Chief Development Officer · Executives · 19 Apr 2025
3,875 shares Common Stock SEC:0000950170-25-056495:0
◇ Chief Executive Officer · Executives · 19 Apr 2025
13,796 shares Common Stock SEC:0000950170-25-056488:0
◇ Chief Executive Officer · Executives · 3 Apr 2025
62,500 shares Common Stock SEC:0000950170-25-050677:0
◆ Director · Executives · 31 Jan 2025
17,950 shares 0Common Stock SEC:0000950170-25-013728:0
◆ Director · Executives · 31 Jan 2025
17,950 shares 0Common Stock SEC:0000950170-25-013770:0
◆ Director · Executives · 31 Jan 2025
17,950 shares 0Common Stock SEC:0000950170-25-013756:0
◆ Director · Executives · 31 Jan 2025
17,950 shares 0Common Stock SEC:0000950170-25-013789:0
◆ Director · Executives · 31 Jan 2025
17,950 shares 0Common Stock SEC:0000950170-25-013741:0
◆ Director · Executives · 31 Jan 2025
17,950 shares 0Common Stock SEC:0000950170-25-013780:0
◆ Director · Executives · 30 Jan 2025
17,950 shares 0Common Stock SEC:0000950170-25-012107:0
◆ Director · Executives · 30 Jan 2025
17,950 shares 0Common Stock SEC:0000950170-25-012119:0
◆ Director · Executives · 30 Jan 2025
17,950 shares 0Common Stock SEC:0000950170-25-012101:0
◆ Director · Executives · 30 Jan 2025
17,950 shares 0Common Stock SEC:0000950170-25-012096:0
◆ Director · Executives · 30 Jan 2025
17,950 shares 0Common Stock SEC:0000950170-25-012043:0
◆ Director · Executives · 30 Jan 2025
17,950 shares 0Common Stock SEC:0000950170-25-012094:0
◇ EVP, Chief Financial Officer · Executives · 19 Jan 2025
3,874 shares Common Stock SEC:0000950170-25-007557:0
◇ EVP, Chief Development Officer · Executives · 19 Jan 2025
3,874 shares Common Stock SEC:0000950170-25-007549:0
25 of 80 declarations
Load more (55 remaining)